TrialNeurology(R) neuroimmunology & neuroinflammation2019

Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS.

Edward J Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.